OCALA, FL / ACCESSWIRE / June 15, 2020 / AIM ImmunoTech (NYSE American:AIM), today provided an update on the commercial launch of Ampligen® for the treatment of severe Chronic Fatigue Syndrome (CFS) ...
AIM 'sets sights' on treating COVID-19 induced chronic fatigue in Argentina Dr. Dan Peterson, M.D. is a world-renowned expert in ME/CFS and head of Sierra Internal Medicine. He is currently an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results